-
Je něco špatně v tomto záznamu ?
Periferní vaskulární kalcifikace u hemodialyzovaných pacientů
[Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences]
Jean G, Bresson E, Errat JC, et al.
Jazyk čeština Země Česko
- MeSH
- chelátory terapeutické užití MeSH
- chronická nemoc MeSH
- dialýza ledvin MeSH
- incidence MeSH
- kalcinóza epidemiologie radiografie MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- nemoci ledvin komplikace mortalita terapie MeSH
- onemocnění periferních cév epidemiologie radiografie MeSH
- polyaminy terapeutické užití MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
Vascular calcifications (VCs) are frequently observed in chronic kidney disease (CKD) and haemodialysis (HD) patients. They have been associated with numerous factors, particularly hyperphosphataemia, excess calcium load, hypertension and increased mortality rate. The purpose of this study is to measure VCs in long-HD patients with good blood pressure and phosphate control, with the occasional use of sevelamer, using a plain radiological score to identify the associated factors and effects on the 1-year survival rate. METHODS: We studied HD patients from one centre using a semi-quantitative score ranging from 0 to 3 according to the severity and extent of VCs. The following patients' characteristics were compared according to their VC scores: medical history, treatments, blood pressure, standard biological data, fibroblast growth factor (FGF) 23, osteoprotegerin (OPG), whole PTH, beta-crosslaps, bone alkaline phosphatases and bone mineral density scores. One-year survival analyses were also performed. RESULTS: Among the 250 HD patients of the centre, 161 were studied; the mean age was 67.2 +/- 13 years, 45% of the subjects were females, 35% were diabetics, and they had been on dialysis for between 1-486 months (median: 45 months) with a 3 x 5-3 x 8 h dialysis schedule using 1.5 mmol/l dialysate calcium and providing a mean 2.25 +/- 0.5 Kt/V. Only 17% of the patients were free from VCs and 11% had severe VCs. The factors associated with VCs were classified into 'classic' (age, diabetes, male gender, tobacco use, inflammation, more frequent warfarin treatment and peripheral vascular and cardiac diseases) and 'non-traditional' (higher FGF-23 and OPG serum levels, low albumin serum levels and low alfacalcidol and CaCO(3) use). In logistic regression, only age, diabetes and FGF-23 serum levels were associated with VC scores of 2 and 3. The patients with a score of 3 had a higher 1-year mortality rate (RR 2.1; P = 0.01) as compared to patients with a 0 score. CONCLUSION: A plain radiological score showed the high prevalence (83%) of VCs in HD patients in spite of a long and intensive dialysis strategy and adherence to guidelines. The main associated factors were classic factors such as ageing and diabetes. No relationship was found with blood pressure and phosphataemia that remained well controlled in long dialysis; the association with FGF-23 serum levels may aggregate some non-traditional risk factors. The harmful effects of VCs on survival require their systematic assessment and optimization of the potentially modifiable associated factors in CKD and HD patients.
Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07526716
- 003
- CZ-PrNML
- 005
- 20111210143434.0
- 008
- 090730s2009 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Jean, G.
- 245 10
- $a Periferní vaskulární kalcifikace u hemodialyzovaných pacientů / $c Jean G, Bresson E, Errat JC, et al.
- 246 11
- $a Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
- 314 __
- $a Centre de Rein Artificiel, Tassin la Demi-lune guillaume-jean-crat@wanadoo.fr
- 520 9_
- $a Vascular calcifications (VCs) are frequently observed in chronic kidney disease (CKD) and haemodialysis (HD) patients. They have been associated with numerous factors, particularly hyperphosphataemia, excess calcium load, hypertension and increased mortality rate. The purpose of this study is to measure VCs in long-HD patients with good blood pressure and phosphate control, with the occasional use of sevelamer, using a plain radiological score to identify the associated factors and effects on the 1-year survival rate. METHODS: We studied HD patients from one centre using a semi-quantitative score ranging from 0 to 3 according to the severity and extent of VCs. The following patients' characteristics were compared according to their VC scores: medical history, treatments, blood pressure, standard biological data, fibroblast growth factor (FGF) 23, osteoprotegerin (OPG), whole PTH, beta-crosslaps, bone alkaline phosphatases and bone mineral density scores. One-year survival analyses were also performed. RESULTS: Among the 250 HD patients of the centre, 161 were studied; the mean age was 67.2 +/- 13 years, 45% of the subjects were females, 35% were diabetics, and they had been on dialysis for between 1-486 months (median: 45 months) with a 3 x 5-3 x 8 h dialysis schedule using 1.5 mmol/l dialysate calcium and providing a mean 2.25 +/- 0.5 Kt/V. Only 17% of the patients were free from VCs and 11% had severe VCs. The factors associated with VCs were classified into 'classic' (age, diabetes, male gender, tobacco use, inflammation, more frequent warfarin treatment and peripheral vascular and cardiac diseases) and 'non-traditional' (higher FGF-23 and OPG serum levels, low albumin serum levels and low alfacalcidol and CaCO(3) use). In logistic regression, only age, diabetes and FGF-23 serum levels were associated with VC scores of 2 and 3. The patients with a score of 3 had a higher 1-year mortality rate (RR 2.1; P = 0.01) as compared to patients with a 0 score. CONCLUSION: A plain radiological score showed the high prevalence (83%) of VCs in HD patients in spite of a long and intensive dialysis strategy and adherence to guidelines. The main associated factors were classic factors such as ageing and diabetes. No relationship was found with blood pressure and phosphataemia that remained well controlled in long dialysis; the association with FGF-23 serum levels may aggregate some non-traditional risk factors. The harmful effects of VCs on survival require their systematic assessment and optimization of the potentially modifiable associated factors in CKD and HD patients.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kalcinóza $x epidemiologie $x radiografie $7 D002114
- 650 _2
- $a chelátory $x terapeutické užití $7 D002614
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a nemoci ledvin $x komplikace $x mortalita $x terapie $7 D007674
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a onemocnění periferních cév $x epidemiologie $x radiografie $7 D016491
- 650 _2
- $a polyaminy $x terapeutické užití $7 D011073
- 650 _2
- $a dialýza ledvin $7 D006435
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a míra přežití $7 D015996
- 700 1_
- $a Bresson, E.
- 700 1_
- $a Errat, J. C.
- 773 0_
- $w MED00012709 $t Postgraduální nefrologie $g Roč. 7, č. 3 (2009), s. 38 $x 1214-178X
- 787 18
- $w bmc07526717 $i Recenze v: $t Komentář [k článku Periferní vaskulární kalcifikace u hemodialyzovaných pacientů]
- 856 41
- $u http://www.transplant.cz/vzdelavani/2009/09_03_04.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2318 $c 893 $y 9
- 990 __
- $a 20090730080340 $b ABA008
- 991 __
- $a 20090907120847 $b ABA008
- 999 __
- $a ok $b bmc $g 670733 $s 529880
- BAS __
- $a 3
- BMC __
- $a 2009 $b 7 $c 3 $d 38 $i 1214-178X $m Postgraduální nefrologie $x MED00012709
- LZP __
- $a 2009-25/mkme